PIL- Topiramate Accord 25mg, 50mg, 100mg, 200mg Film-coated Tablets: Change history
View Patient Information Leaflet (PIL- Topiramate Accord 25mg, 50mg, 100mg, 200mg Film-coated Tablets)
Last updated on this site: 11 May 2023
Description of update: The proposed change is: C.I.2.a; Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet of a generic/hybrid/biosimilar medicinal products following assessment of the same change for the reference product; Implementation of change(s) for which no new additional data is required to be submitted by the MAH - variation to update SmPC and PIL information in line with the product information of reference product (Topamax 25mg, 50mg, 100mg and 200mg tablets with Procedure reference number: SE/H/0110/001-009
The date of approval is 04-MAY-2023.
PIL sections updated: Introduction, 3, 4, 6.
Last updated on this site: 11 May 2023
Description of update: The proposed change is: C.I.2.a; Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet of a generic/hybrid/biosimilar medicinal products following assessment of the same change for the reference product; Implementation of change(s) for which no new additional data is required to be submitted by the MAH - variation to update SmPC and PIL information in line with the product information of reference product (Topamax 25mg, 50mg, 100mg and 200mg tablets with Procedure reference number: SE/H/0110/001-009
The date of approval is 04-MAY-2023.
PIL sections updated: Introduction, 3, 4, 6.
-
Changes: (Updated: 11 May 2023)
Description of update: The proposed change is: C.I.2.a; Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet of a generic/hybrid/biosimilar medicinal products following assessment of the same change for the reference product; Implementation of change(s) for which no new additional data is required to be submitted by the MAH - variation to update SmPC and PIL information in line with the product information of reference product (Topamax 25mg, 50mg, 100mg and 200mg tablets with Procedure reference number: SE/H/0110/001-009
The date of approval is 04-MAY-2023.
PIL sections updated: Introduction, 3, 4, 6.
-
Changes: (Updated: 09 Nov 2022)
Updated
-
Changes: (Updated: 22 Sep 2022)
initial upload